Physician profile
Blake A Weeks
NPI 1205191640
$4,117.18
in general payments reported to CMS, 2019-2025
40 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,301 · 2020: $571 · 2021: $183 · 2022: $244 · 2023: $635 · 2024: $702 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,817.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $763.57 | 2019-2020 | |
| Organogenesis INC. | $475.24 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $473.59 | 2019-2025 | Collagenase Santyl, Regranex, Pico 7 |
| Paratek Pharmaceuticals, INC. | $199.81 | 2024-2025 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $181.34 | 2020-2022 | |
| Kerecis Limited | $176.59 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Piedmont Plus Innovation | $156.25 | 2024-2025 | |
| Integra Lifesciences Corporation | $123.42 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Lifenet Health | $122.31 | 2023-2024 | Theragenesis Wound Matrix |
| Peerless Surgical INC. | $110.00 | 2020 | |
| Abbott Laboratories | $104.21 | 2020-2025 | Proclaim, Eterna |
| Bioventus LLC | $92.55 | 2021-2023 | |
| Progenacare Global, LLC | $89.68 | 2023 | |
| Next Science LLC | $86.92 | 2023 | Xperience, Blastx, Surgx |
| Tactile Systems Technology INC | $84.73 | 2019-2023 | Entre Plus, Flexitouch Plus |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $77.19 | 2019 | |
| Avita Medical Americas, LLC | $75.71 | 2025 | Cohealyx, Permeaderm, Recell |
| Treace Medical Concepts, INC. | $71.92 | 2024-2025 | |
| Inari Medical, INC. | $69.55 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $61.36 | 2021-2023 | Rybelsus, Ozempic |
| Horizon Therapeutics Plc | $46.18 | 2019-2021 | |
| Ets Wound Care LLC | $45.89 | 2023 | |
| Grt US Holding, INC. | $42.46 | 2020-2022 | |
| Cashflow Solutions, LLC | $41.92 | 2024-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Abbvie INC. | $37.66 | 2022-2025 | |
| Amgen INC. | $36.37 | 2024-2025 | Krystexxa |
| Nevro Corp. | $34.19 | 2022-2024 | Senza |
| Sanara Medtech INC. | $27.05 | 2023 | Celleraterx |
| Mimedx Group, INC. | $23.05 | 2024 | |
| Ascensia Diabetes Care US INC. | $22.56 | 2024 | |
| Averitas Pharma INC. | $20.72 | 2025 | Qutenza |
| Tei Medical INC. | $19.64 | 2019 | |
| Kaleo, INC. | $18.58 | 2020 | |
| Triad Life Sciences INC. | $16.48 | 2022 | |
| Dexcom, INC. | $16.26 | 2021 | |
| Orthofix Medical, INC. | $16.11 | 2024 | Accelstim, Physio-Stim |
| Nabriva Therapeutics, Plc | $15.91 | 2022 | |
| Hikma Pharmaceuticals USA | $13.81 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.63 | 2023 | Seglentis |
| Misonix INC | $12.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Weeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.